Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage

Stroke. 2010 Dec;41(12):2976-8. doi: 10.1161/STROKEAHA.110.595868.

Abstract

Background and purpose: We tested the hypothesis that proteins of hemostasia could be associated with hematoma growth (HG) in patients with acute intracerebral hemorrhage.

Methods: We prospectively studied patients with spontaneous supratentorial intracerebral hemorrhage within the first 6 hours after the onset of symptoms. HG was defined as an increase > 33% in the volume of hematoma on CT obtained 24 to 72 hours after the onset of symptoms in comparison with the CT obtained at admission. We collected admission and follow-up blood samples. We measured fibrinogen, factor XIII, thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor, plasminogen, α₂-antiplasmin, tissue plasminogen activator, d-dimer, thrombomodulin, thrombin-antithrombin complex, and plasmin-antiplasmin complex.

Results: We included 90 patients with a mean age of 71 ± 10.8 years; 61% were men. HG was observed in 35 (39%) of the patients. Mean baseline and follow-up protein measurements showed no difference between the groups with and without HG. The analysis of variance showed that factor XIII activity decreased in the non-HG group in the 24 to 72 hours sample, whereas it increased in the HG group (P = 0.001).

Conclusions: Factor XIII was the only measured protein related to HG. The levels at the follow-up sample decreased in the non-HG group and increased in the HG group. Further studies are needed to confirm this association.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Analysis of Variance
  • Anticoagulants / therapeutic use
  • Blood Proteins / physiology*
  • Cerebral Hemorrhage / diagnostic imaging
  • Cerebral Hemorrhage / pathology*
  • Disease Progression
  • Factor XIII / physiology
  • Female
  • Hematoma / diagnostic imaging
  • Hematoma / pathology
  • Hemostasis / physiology*
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Tomography, X-Ray Computed

Substances

  • Anticoagulants
  • Blood Proteins
  • Factor XIII